Skip to main content
. 2022 May 26;23(11):6000. doi: 10.3390/ijms23116000
AAS antibiotic–antimycotic solution
AD Alzheimer’s Disease
ALS amyotrophic lateral sclerosis
CNS central nervous system
DIV days in vitro
DMEM Dulbecco’s Modified Eagle’s Medium
EAAT1 glutamate aspartate transporter 1, GLAST-1
ECM Gel Extracellular Matrix Gel, Matrigel
FBR fibronectin
FBS fetal bovine serum
GS glutamine synthetase
ITS Insulin-Transferrin-Selenium-A Solution
LAM laminin
LPS lipopolysaccharide
MS multiple sclerosis
NG2 cells oligodendrocyte progenitors
OGD oxygen-glucose deprivation
OPCs oligodendrocyte progenitor cells
PFA paraformaldehyde
PLL poly-L-lysine hydrobromide
RT room temperature
TNFα tumor necrosis factor α